Back to Explore Funds
equity Fund

Pharma & Healthcare Funds

Invest in pharmaceutical, biotech, and healthcare companies across India.

Avg. Return (5Y)

15.68%

No. of Funds

9

Risk Level

Very High

Ideal Horizon

5+ years

Top Pharma & Healthcare Funds Sorted by Returns

SBI MF logo

SBI Healthcare Opportunities Fund

SBI MF

Expense: 0.92%
1Y: 16.2%
3Y: 18.5%
5Y: 17.1%
Nippon India MF logo

Nippon India Pharma Fund

Nippon India MF

Expense: 1.05%
1Y: 15.1%
3Y: 17.8%
5Y: 16.4%
DSP MF logo

DSP Healthcare Fund

DSP MF

Expense: 0.88%
1Y: 14.5%
3Y: 16.9%
5Y: 15.8%

* Returns are annualized and based on historical data. Past performance does not guarantee future results. Min. SIP: ₹500.

What is a Pharma & Healthcare Fund?

Pharma and healthcare funds invest in pharmaceutical companies, hospitals, diagnostics, medical devices, and biotech firms. India is the pharmacy of the world, and these funds capture that structural advantage.

Key Advantages

  • India's pharmacy-of-the-world advantage
  • Defensive sector with steady demand
  • Growing domestic healthcare spending
  • Export potential to US and global markets

How It Works

At least 80% is invested in pharma and healthcare stocks. The portfolio includes generics manufacturers, API producers, hospital chains, and diagnostic companies.

Who Should Invest?

  • Investors seeking healthcare sector exposure
  • Those looking for a defensive equity allocation
  • Investors bullish on India's pharma export story

Taxation

Same equity taxation — STCG at 20%, LTCG tax-free up to ₹1.25L, 12.5% above.

Frequently Asked Questions

Finlec

Finlec helps you explore mutual funds, start SIPs, and manage your investments from one place.

Get in Touch

2nd Floor, Saikripa Building, Trimurti Chowk, Pune-46
investor@finlec.in9420151046

Investing in Mutual Fund Portfolios

A portfolio is a mix of mutual funds built around your goals, time horizon, and risk comfort. It helps diversify your investments and keeps your savings plan organized. You can build one yourself or ask an expert to help.

Disclaimer

Finlec India is a member of BSE Star MF (Member Code 55269) and a mutual fund distributor with AMFI Registration No: ARN-225204. Registered and correspondence office: 2nd Floor, Saikripa Building, Trimurti Chowk, Pune-46.

Finlec India makes no express or implied warranties on products offered through the platform. It accepts no liability for losses arising from the use of the platform or reliance on related services. Unless stated otherwise, returns, expense ratios, NAV, and similar figures are historical and shown only for illustration. Future returns can vary significantly based on market conditions and individual circumstances.

The information shared on our blog is for education only and does not constitute investment or tax advice.

About Finlec

FINLEC is an investment platform that helps users discover mutual funds and invest with ease. FINLEC provides fund information and evaluation tools, but all investment decisions should be made at the investor's own discretion. FINLEC does not guarantee returns or capital protection.

FINLEC helps investors in the following way:

  • By showing clear information about the products available on FINLEC
  • By helping investors understand the risks involved before they invest

Secure Transactions on Finlec

Transactions on FINLEC are processed through supported banking channels for SIP and lump sum investments. FINLEC uses BSE Star MF (Member Code 55269) as the transaction platform.

Mutual Funds Sahi Hai

Mutual funds are popular because they let investors start with a small amount, diversify across assets, and invest toward different goals. A wide range of mutual fund categories is available on FINLEC.

Mutual fund investments are subject to market risk. Please read all scheme-related documents carefully before investing. Past performance is neither an indicator nor a guarantee of future performance.

Terms and conditions of the website and app apply. The website privacy policy also applies.

© 2026 Finlec. All rights reserved. Developed by Finlec Technologies.